Immunodeficiency Clinic


This 12-month program for advanced degree pharmacists will provide the resident with experience in a variety of HIV clinical settings, with a focus on ambulatory care (other rotations include inpatient services, community pharmacy, family practice clinics, drug information/marketing, pediatrics, therapeutic drug monitoring, consulting, community AIDS groups, and infectious diseases). The resident will be expected to initiate and complete a research project. The resident will also have teaching responsibilities for B.Sc.Phm. / M.Sc. hospital residents and Pharm.D. candidates doing elective HIV ambulatory rotations.

Please review the HIV Residency Program Manual for more detailed information on the program.

The primary preceptors are Alice Tseng, Pharm.D., University Health Network, Assistant Professor, Faculty of Pharmacy, University of Toronto, and Nancy Sheehan, B.Pharm, M.Sc., McGill University Health Centre, Assistant Clinical Professor, Faculty of Pharmacy, University of Montréal.  The Immunodeficiency Clinic, University Health Network in Toronto, and Immunodeficiency Service, McGill University Health Centre in Montreal, are 2 of the largest, university-affiliated, outpatient HIV clinics in Canada, serving together over 2500 patients per year. Primary and specialty care is provided through a comprehensive interdisciplinary approach (including medicine, pharmacy, nursing, social work, nutrition, and psychology). Other priorities include clinical research, outreach programs, and antiretroviral therapeutic drug monitoring.

Applicants should possess a Pharm.D. or M.Sc.Phm. degree (or equivalent experience) and have completed a CSHP- or ASHP-accredited (PGY1) residency program. The desired starting date is July-August of each year.  The option to complete a 2 year combined Residency/Master`s program is also available. Upon completion of this program, the resident will be awarded both a Specialty Residency Certificate and a M.Sc.Phm. degree from the University of Toronto.

The annual stipend for the resident is $40,000 Canadian. Funding for the HIV Pharmacy Specialty Residency has been provided through unrestricted educational grants from GlaxoSmithKline, Merck Frosst Canada Inc., and Pfizer Canada.

Interested applicants should send a cover letter describing their interest, a curriculum vitae, and two letters of reference before March 1st to both:

HIV Pharmacy Specialty
Residency Program

Additional Information

HIV Residency Program Manual

Tseng A, Foisy M, Bajcar J, Musing E, Wells J, Grondin M, Salit I.
Development of an HIV Pharmacy Practice Specialty Residency (Article)
Am J Health-Syst Pharm 2001;58:591-4.

Alice Tseng, Pharm.D., FCSHP
Immunodeficiency Clinic
Toronto General Hospital, 13N-1314
585 University Avenue
Toronto, Ontario, M5G 2N2
phone: (416) 340-4800, ext. 8763
fax: (416) 340-4890

Nancy Sheehan, M.Sc.Phm.
Immunodeficiency Clinic,
McGill University Health Centre
Montréal Chest Institute
3650 rue St-Urbain
Montréal, Québec H2X 2P4
Phone: 514-343-6111, ext 0884
Fax: 514-849-1709

Terms & Conditions  |  Privacy Policy  |  Copyright 2010
Immunodeficiency Clinic, 585 University Avenue, Toronto, ON

The HIV Pharmacy Speciality Residency is a joint program of the University Health Network and McGill University Health Centre, in conjunction with the Leslie Dan Faculty of Pharmacy, University of Toronto.

Home      Clinic      Patients     Drug Information     Research      Residency      Pharmacy Org